{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:13:29Z","timestamp":1791249209522,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15390560"],"award-info":[{"award-number":["15390560"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.bone.2006.11.030","type":"journal-article","created":{"date-parts":[[2007,2,10]],"date-time":"2007-02-10T07:12:44Z","timestamp":1171091564000},"page":"273-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLC\u03b3-activated STAT1"],"prefix":"10.1016","volume":"41","author":[{"given":"Daisuke","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koso","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Seino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2006.11.030_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bone.2006.11.030_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bone.2006.11.030_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng0795-357","article-title":"A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia","volume":"10","author":"Bellus","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2006.11.030_bib4","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/316892","article-title":"Distinct missense mutations of the FGFR3 Lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype","volume":"67","author":"Bellus","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2006.11.030_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (type I and type II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2006.11.030_bib6","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/hmg\/4.11.2175","article-title":"Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I","volume":"4","author":"Tavormina","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2006.11.030_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ng0595-11","article-title":"Stop codon FGFR3 mutation in thanatophoric dwarfism Type I","volume":"10","author":"Rousseau","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2006.11.030_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/302275","article-title":"A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene","volume":"64","author":"Tavormina","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"342 Pt. 3","key":"10.1016\/j.bone.2006.11.030_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/bj3420677","article-title":"Differential effects of fibroblast growth factor (FGF) 9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro","volume":"15","author":"Weksler","year":"1999","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bone.2006.11.030_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1043-2760(98)00120-9","article-title":"Control of bone growth by fibroblast growth factors","volume":"10","author":"De Luca","year":"1999","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2006.11.030_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bone.2003.09.002","article-title":"Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias","volume":"34","author":"Legeai-Mallet","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.11.030_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat. Genet."},{"issue":"19","key":"10.1016\/j.bone.2006.11.030_bib13","doi-asserted-by":"crossref","first-page":"17344","DOI":"10.1074\/jbc.M212710200","article-title":"The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum","volume":"278","author":"Lievens","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.bone.2006.11.030_bib14","doi-asserted-by":"crossref","first-page":"43254","DOI":"10.1074\/jbc.M405247200","article-title":"The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling","volume":"279","author":"Lievens","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"6622","key":"10.1016\/j.bone.2006.11.030_bib15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/386288a0","article-title":"Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism","volume":"386","author":"Su","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bone.2006.11.030_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","article-title":"A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors","volume":"8","author":"Li","year":"1999","journal-title":"Hum. Mol. Genet."},{"issue":"29","key":"10.1016\/j.bone.2006.11.030_bib17","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/sj.onc.1203650","article-title":"Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4","volume":"19","author":"Hart","year":"2000","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bone.2006.11.030_bib18","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1101\/gad.13.11.1361","article-title":"FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway","volume":"13","author":"Sahni","year":"1999","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.bone.2006.11.030_bib19","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1242\/dev.128.11.2119","article-title":"STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2","volume":"128","author":"Sahni","year":"2001","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.bone.2006.11.030_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/mol.65.3.589","article-title":"Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase C gamma, c-Src, and STAT1","volume":"65","author":"Chang","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bone.2006.11.030_bib21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/mi.2.6.352","article-title":"Phospholipase C-\u03b31: a phospholipase and guanine nucleotide exchange factor","volume":"2","author":"Moran","year":"2002","journal-title":"Mol. Interv."},{"issue":"10","key":"10.1016\/j.bone.2006.11.030_bib22","first-page":"5068","article-title":"A Tyrosine-Phosphorylated Carboxy-Terminal Peptide of the Fibroblast Growth Factor Receptor (Flg) Is a Binding Site for the SH2 Domain of Phospholipase C-gamma l","volume":"11","author":"Mohammadi","year":"1991","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.bone.2006.11.030_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1083\/jcb.133.2.457","article-title":"Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)\/PTH-related peptide receptor","volume":"133","author":"Shukunami","year":"1996","journal-title":"J. Cell Biol."},{"issue":"30","key":"10.1016\/j.bone.2006.11.030_bib24","doi-asserted-by":"crossref","first-page":"21844","DOI":"10.1016\/S0021-9258(19)36689-X","article-title":"Inhibitory effect of src homology (SH) 2\/SH3 fragments of phospholipase C-gamma on the catalytic activity of phospholipase C isoforms. Identification of a novel phospholipase C inhibitor region","volume":"267","author":"Homma","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bone.2006.11.030_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bone.2006.11.030_bib26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1359\/jbmr.2003.18.8.1395","article-title":"PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation","volume":"18","author":"Yamanaka","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.11.030_bib27","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1359\/jbmr.2003.18.11.2043","article-title":"Insulin-like growth factor-1 rescues he mutated FGF Receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK","volume":"18","author":"Koike","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bone.2006.11.030_bib28","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1128\/MCB.17.9.5328","article-title":"Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis","volume":"17","author":"Chin","year":"1997","journal-title":"Mol. Cell. Biol."},{"issue":"5343","key":"10.1016\/j.bone.2006.11.030_bib29","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.278.5343.1630","article-title":"Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases","volume":"278","author":"Kumar","year":"1997","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.bone.2006.11.030_bib30","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1158\/0008-5472.CAN-04-1864","article-title":"STAT1: a modulator of chemotherapy-induced apoptosis","volume":"64","author":"Thomas","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2006.11.030_bib31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1091\/mbc.12.4.931","article-title":"Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, stat activation, and phosphatidylinositol 3-kinase activation","volume":"22","author":"Hart","year":"2001","journal-title":"Mol. Biol. Cell"},{"issue":"20","key":"10.1016\/j.bone.2006.11.030_bib32","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1038\/sj.onc.1201789","article-title":"FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells","volume":"16","author":"Johnson","year":"1998","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bone.2006.11.030_bib33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<476::AID-AJMG12>3.0.CO;2-X","article-title":"Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations","volume":"84","author":"Brodie","year":"1999","journal-title":"Am. J. Med. Genet."},{"issue":"5","key":"10.1016\/j.bone.2006.11.030_bib34","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.2002.17.5.860","article-title":"Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization","volume":"17","author":"Adar","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2006.11.030_bib35","first-page":"95","article-title":"Hypochondroplasia","volume":"26","author":"Newman","year":"1975","journal-title":"J. Can. Assoc. Radiol."},{"issue":"4","key":"10.1016\/j.bone.2006.11.030_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00355348","article-title":"A new neonatal short limbed dwarfism","volume":"13","author":"McAlister","year":"1985","journal-title":"Skelet. Radiol."},{"issue":"4","key":"10.1016\/j.bone.2006.11.030_bib37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ajmg.1320220404","article-title":"Thanatophoric dysplasia: fetal manifestations and prenatal diagnosis","volume":"22","author":"Elejalde","year":"1985","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bone.2006.11.030_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2005.02.003","article-title":"FGF signaling in the developing endochondral skeleton","volume":"16","author":"Ornitz","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bone.2006.11.030_bib39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yexcr.2004.11.012","article-title":"Cell responses to FGFR3 signaling: growth, differentiation and apoptosis","volume":"304","author":"L'Hote","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bone.2006.11.030_bib40","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1074\/jbc.M310384200","article-title":"Activation of the ERK1\/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes","volume":"279","author":"Raucci","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bone.2006.11.030_bib41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s007740050095","article-title":"Immunohistochemical localization of fibroblast growth factor receptors in the rat mandibular condylar cartilage and tibial cartilage","volume":"17","author":"Hamada","year":"1999","journal-title":"J. Bone Miner. Metab."},{"issue":"1","key":"10.1016\/j.bone.2006.11.030_bib42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2004-09-3686","article-title":"Constitutively activated FGFR3 mutants signal through PLC{gamma}-dependent and -independent pathways for hematopoietic transformation","volume":"106","author":"Chen","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bone.2006.11.030_bib43","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jmb.2006.01.058","article-title":"K644E\/M FGFR3 mutants activate Erk1\/2 from the endoplasmic reticulum through FRS2alpha and PLC gamma-independent pathways","volume":"357","author":"Lievens","year":"2006","journal-title":"J. Mol. Biol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632820600843X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632820600843X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:32:58Z","timestamp":1757611978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632820600843X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S875632820600843X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2006.11.030","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLC\u03b3-activated STAT1","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2006.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}